Foley Partner Ethan Lenz and Senior Counsel Max Chester authored an article that appeared in Risk & Insurance on November 21, 2011 titled “The FCPA and Insurance: Am I Covered or Should I Be?” The authors discuss a number of questions that a company should ask when evaluating the purchase of specific Foreign Corrupt Practices Act (FCPA) investigation cost insurance. They state that products addressing exposures to FCPA enforcement-related costs should be closely scrutinized against a company’s existing coverage and risk profile to determine if the benefits of additional coverage are warranted.
Click here to read the complete article.
Author(s)
Related Insights
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Colorado Medicaid: RAC Program Overhauled with Enhanced Transparency, Greater Provider Protections, and Increased Oversight
In June 2025, Colorado passed a new law that makes significant changes to the state’s Medicaid Recovery Audit Contractor (RAC) program….